AMGN compared with EXOZ: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

EXOZExozymes Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

EXOZExozymes Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

EXOZ: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No disclosed counterparties: EXOZ.

Only EXOZ 0

None

Role chip = supplier or customerSource: SEC EDGAR

AMGNAmgen Inc

461.49· pre 452.20· delayed

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

EXOZExozymes Inc.

3.93· pre 4.39· delayed

Pre-marketNov 6 '26delayed

Mkt cap$35.6MRevenue—Revenue—

Compare

Pre-marketNov 6 '26delayed

AMGNAmgen Inc

EXOZExozymes Inc.

461.49pre 452.20delayed

Price

3.93pre 4.39delayed

$249.0B

Mkt cap

$35.6M

Q3 FY26$10.4B

Revenue

—

FY25$36.8B

Revenue

—

AMGN461.49vsEXOZ3.93Pre-marketNov 6 '26delayed

Price

rebased to 0%

AMGN, solidEXOZ, dashed